MUC1-induced transcriptional programs associated with tumorigenesis predict outcome in breast and lung cancer.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Cancer Research

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-08-4513PMID 19318547PMCID PMC3034477
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cytoplasmic Tail of MUC1: A Very Busy Place

  2008cited by this paper
• Gene expression–based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study

  2008cited by this paper
• Circulating KL‐6/MUC1 mucin carrying sialyl Lewisa oligosaccharide is an independent prognostic factor in patients with lung adenocarcinoma

  2007cited by this paper
• Evolution of the human MUC1 oncoprotein.

  2007cited by this paper
• MUC1 Oncoprotein Stabilizes and Activates Estrogen Receptor α

  2006cited by this paper
• CA 15-3 is predictive of response and disease recurrence following treatment in locally advanced breast cancer

  2006cited by this paper
• Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin

  2006cited by this paper
• Cell surface-associated mucins in signal transduction.

  2006cited by this paper
• MUC1 oncoprotein stabilizes and activates estrogen receptor alpha.

  2006cited by this paper
• Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response.

  2005cited by this paper
• Progression of Barrett's metaplasia to adenocarcinoma is associated with the suppression of the transcriptional programs of epidermal differentiation.

  2005cited by this paper
• MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of beta-catenin.

  2005cited by this paper
• Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival.

  2005cited by this paper
• Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC).

  2004cited by this paper
• The MUC1 Oncoprotein Activates the Anti-apoptotic Phosphoinositide 3-Kinase/Akt and Bcl-xL Pathways in Rat 3Y1 Fibroblasts*

  2004cited by this paper
• STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells.

  2004cited by this paper
• Human MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents.

  2004cited by this paper
• Receiver operating characteristic analysis: a general tool for DNA array data filtration and performance estimation.

  2003cited by this paper
• Human DF3/MUC1 carcinoma-associated protein functions as an oncogene

  2003cited by this paper
• Human MUC1 Carcinoma Antigen Regulates Intracellular Oxidant Levels and the Apoptotic Response to Oxidative Stress*

  2003cited by this paper
• Method of RNA purification from endothelial cells for DNA array experiments.

  2002cited by this paper
• Combined effects of angiostatin and ionizing radiation in antitumour therapy

  1998cited by this paper
• Cell-associated episialin is a complex containing two proteins derived from a common precursor.

  1992cited by this paper
• Frequent alteration of the DF3 tumor-associated antigen gene in primary human breast carcinomas.

  1989cited by this paper
• Isolation and sequencing of a cDNA coding for the human DF3 breast carcinoma-associated antigen.

  1988cited by this paper
• Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant versus Benign Breast Tumors

  1984cited by this paper

• MUC1-C dependency in drug resistant HR+/HER2− breast cancer identifies a new target for antibody-drug conjugate treatment

  2025cites this paper
• M1C is a druggable target for NSCLC KRAS G12C mutant tumors resistant to KRAS inhibitors

  2025cites this paper
• Molecular mechanisms of mTOR-mediated cisplatin response in tumor cells

  2024cites this paper
• MUC1 Expressions and Its Prognostic Values in US Gastric Cancer Patients

  2023cites this paper
• MUC1-C IS A COMMON DRIVER OF ACQUIRED OSIMERTINIB RESISTANCE IN NON-SMALL CELL LUNG CANCER.

  2023cites this paper
• Single CAR-T cell treatment controls disseminated ovarian cancer in a syngeneic mouse model

  2023cites this paper
• Possible correlation of apical localization of MUC1 glycoprotein with luminal A-like status of breast cancer

  2023cites this paper
• MUC1 triggers lineage plasticity of Her2 positive mammary tumors

  2022cites this paper
• MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy

  2022cites this paper
• Core 2 β1,6-N-acetylglucosaminyltransferases accelerate the escape of choriocarcinoma from natural killer cell immunity

  2021cites this paper
• Mucins: Structure and Function

  2021cites this paper
• Role of EIF4G1 network in non‐small cell lung cancers (NSCLC) cell survival and disease progression

  2021cites this paper
• Muc1-c in chronic inflammation and carcinogenesis;emergence as a target for cancer treatment.

  2020cites this paper
• A SERS-colorimetric dual-mode aptasensor for the detection of cancer biomarker MUC1

  2020cites this paper
• Role of the MUC1‐C oncoprotein in the acquisition of cisplatin resistance by urothelial carcinoma

  2020cites this paper
• A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer

  2019cites this paper
• A Phase I Dose-Escalation Trial of BN-CV301, a Recombinant Poxviral Vaccine Targeting MUC1 and CEA with Costimulatory Molecules

  2019cites this paper
• Functional Expression of Mucin1 in Human Duodenal Adenocarcinoma.

  2019cites this paper
• Interaction Between MUC1 and STAT1 Drives IFITM1 Overexpression in Aromatase Inhibitor–Resistant Breast Cancer Cells and Mediates Estrogen-Induced Apoptosis

  2019influential citation
• Anti-KL-6/MUC1 monoclonal antibody reverses resistance to trastuzumab-mediated antibody-dependent cell-mediated cytotoxicity by capping MUC1.

  2019cites this paper
• MiR-145: a potential biomarker of cancer migration and invasion.

  2019cites this paper
• MUC1-C activates polycomb repressive complexes and downregulates tumor suppressor genes in human cancer cells

  2018cites this paper
• Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate.

  2018cites this paper
• Glycosylation Changes in Brain Cancer.

  2017cites this paper
• Lewis(y) antigen promotes the progression of epithelial ovarian cancer by stimulating MUC1 expression

  2017cites this paper
• Fluorescence Sensing Using DNA Aptamers in Cancer Research and Clinical Diagnostics

  2017cites this paper
• MUC1-C INTEGRATES PD-L1 INDUCTION WITH REPRESSION OF IMMUNE EFFECTORS IN NON-SMALL CELL LUNG CANCER

  2017cites this paper
• Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factor-alpha and dexamethasone

  2017cites this paper
• MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer

  2017cites this paper
• Downregulation of lysosomal and further gene expression characterization in lung cancer patients with bone metastasis

  2017cites this paper
• MUC1: The First Respiratory Mucin with an Anti-Inflammatory Function

  2017cites this paper
• MUC1 overexpression predicts worse survival in patients with non-small cell lung cancer: evidence from an updated meta-analysis

  2017cites this paper
• MUC1 induces M2 type macrophage influx during postpartum mammary gland involution and triggers breast cancer

  2017cites this paper
• Mucoepidermoid carcinoma-associated expression of MUC5AC, MUC5B and mucin-type carbohydrate antigen sialyl-Tn in the parotid gland.

  2017cites this paper
• MUC1 induces acquired chemoresistance by upregulating ABCB1 in EGFR-dependent manner

  2017cites this paper
• Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells

  2016cites this paper
• Inhibition of MUC1-C Suppresses MYC Expression and Attenuates Malignant Growth in KRAS Mutant Lung Adenocarcinomas.

  2016cites this paper
• MUC5AC interactions with integrin β4 enhances the migration of lung cancer cells through FAK signaling

  2016cites this paper
• Development and application of a double- antibody sandwich ELISA kit for the detection of serum MUC1 in lung cancer patients

  2016influential citation
• The promise of protein glycosylation for personalised medicine.

  2016cites this paper
• Molecular Pathways: Mucins and Drug Delivery in Cancer

  2016cites this paper
• Mucins in Lung Cancer: Diagnostic, Prognostic, and Therapeutic Implications

  2015cites this paper
• Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome

  2015influential citation
• Glycosylation alterations in lung and brain cancer.

  2015cites this paper
• Establishment of a heterotypic 3D culture system to evaluate the interaction of TREG lymphocytes and NK cells with breast cancer.

  2015cites this paper
• Microenvironment, tumor cell plasticity, and cancer

  2015cites this paper
• The generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

  2015cites this paper
• Signature moléculaire des adénocarcinomes pulmonaires de type lépidique prédominant et mucineux invasif et dérégulation

  2015cites this paper
• The generation and analysis of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic

  2015cites this paper
• 3-Dimensional reconstruction of the breast tumour microenvironment: mediation of tumour progression by T(REG) lymphocytes and NK cells

  2015cites this paper
• Tumor responsive targeted multifunctional nanosystems for cancer imaging, chemo- and siRNA therapy

  2015cites this paper
• Update on Mucin-1 immunotherapy in cancer: a clinical perspective

  2015cites this paper
• MUC1-C ACTIVATES THE TAK1 INFLAMMATORY PATHWAY IN COLON CANCER

  2015influential citation
• Robust meta-analysis of gene expression using the elastic net

  2015cites this paper
• Low miR-145 silenced by DNA methylation promotes NSCLC cell proliferation, migration and invasion by targeting mucin 1

  2015cites this paper
• MUC1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells

  2014cites this paper
• Adenoviral vectors for prodrug activation-based gene therapy for cancer.

  2014cites this paper
• Antitumor Effects of Cisplatin Combined with Tecemotide Immunotherapy in a Human MUC1 Transgenic Lung Cancer Mouse Model

  2014cites this paper
• Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

  2014cites this paper
• 1 TARGETING THE ONCOGENIC MUC 1-C PROTEIN INHIBITS MUTANT EGFR-MEDIATED SIGNALING AND SURVIVAL IN NON-SMALL CELL LUNG CANCER CELLS

  2014cites this paper
• Characterising the role of anterior gradient protein 2 in cell adhesion and metastasis

  2014cites this paper
• Regulation by IL-10 of innate immune responses to MUC1 as a self-antigen in MUC1 transgenic mice

  2014cites this paper
• Targeting the Oncogenic MUC1-C Protein Inhibits Mutant EGFR-Mediated Signaling and Survival in Non–Small Cell Lung Cancer Cells

  2014cites this paper
• MUC 1-C confers EMT and KRAS independence in mutant KRAS lung cancer cells

  2014cites this paper
• Tumor carbohydrate antigens and strategies to develop cancer vaccines and drugs

  2013cites this paper
• Evaluation of Mucin-1 protein and mRNA expression as prognostic and predictive markers after neoadjuvant chemotherapy for breast cancer.

  2013cites this paper
• Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models

  2013cites this paper
• Antitumor effects of L-BLP25 Antigen-Specific tumor immunotherapy in a novel human MUC1 transgenic lung cancer mouse model

  2013influential citation
• Anti‐adhesive property of P‐selectin glycoprotein ligand‐1 (PSGL‐1) due to steric hindrance effect

  2013cites this paper
• Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues.

  2013cites this paper
• MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches

  2013cites this paper
• Targeting C4-demethylating genes in the cholesterol pathway sensitizes cancer cells to EGF receptor inhibitors via increased EGF receptor degradation.

  2013cites this paper
• Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

  2013cites this paper
• Prognostic significance of membrane-associated mucins 1 and 4 in gastric adenocarcinoma.

  2012cites this paper
• MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase.

  2012cites this paper
• The effect of p53 on function of TFAP2C in breast cancer: detailed analysis of regulation of MUC1 gene

  2012cites this paper
• Cooperative Interaction between the MUC1-C Oncoprotein and the Rab31 GTPase in Estrogen Receptor-Positive Breast Cancer Cells

  2012cites this paper
• of core 2 6-N-acetylglucosaminyltransferase and -galactoside 2,3-sialyltransferase

  2012cites this paper
• Natural and Induced Humoral Responses to MUC1

  2011cites this paper
• Androgen receptor regulates expression of the MUC1‐C oncoprotein in human prostate cancer cells

  2011cites this paper
• CCL21 modulates the migration of NSCL cancer by changing the concentration of intracellular Ca2+.

  2011cites this paper
• A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer

  2011cites this paper
• Prediction Of Survival Of Early Stages Lung Cancer Patients Based On Er Beta Cellular Expressions And Epidemiological Data

  2011cites this paper
• The role of tumor hypoxia in MUC1-positive breast carcinomas

  2011cites this paper
• Replication-competent adenovirus 11p vector as a new oncolytic agent

  2011cites this paper
• Overexpression of MUC1 Enhances Proangiogenic Activity of Non-Small-Cell Lung Cancer Cells Through Activation of Akt and Extracellular Signal-regulated Kinase Pathways

  2011cites this paper
• Mucin 1 C-Terminal Subunit Oncoprotein Is a Target for Small-Molecule Inhibitors

  2011cites this paper
• Dependence on the MUC1-C Oncoprotein in Non–Small Cell Lung Cancer Cells

  2011cites this paper
• A Monoclonal Antibody Against the Oncogenic Mucin 1 Cytoplasmic Domain

  2011influential citation
• MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells

  2011cites this paper
• Therapeutic Discovery Dependence on the MUC 1-C Oncoprotein in Non – Small Cell Lung Cancer Cells

  2011cites this paper
• Dual E 1 A oncolytic adenovirus : targeting tumor heterogeneity with two independent cancer-specific promoter elements , DF 3 / MUC 1 and hTERT

  2011cites this paper
• Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy.

  2011cites this paper
• Integrating the multiple dimensions of genomic and epigenomic landscapes of cancer

  2010cites this paper
• MUC 1-Associated Proliferation Signature Predicts Outcomes in Lung Adenocarcinoma Patients

  2010influential citation
• MUC1-C Oncoprotein Interacts Directly with ATM and Promotes the DNA Damage Response to Ionizing Radiation.

  2010cites this paper
• Maintenance and Consolidation Therapy in Patients with Unresectable Stage III/IV Non-Small Cell Lung Cancer

  2010cites this paper
• PDEF and PDEF-induced proteins as candidate tumor antigens for T cell and antibody-mediated immunotherapy of breast cancer

  2010cites this paper
• Dual E1A Oncolytic Adenovirus: Targeting Tumor Heterogeneity With Two Independent Cancer-specific Promoter Elements, DF3/MUC1 and hTERT

  2010cites this paper
• MUC1-associated proliferation signature predicts outcomes in lung adenocarcinoma patients

  2010cites this paper